Viewing StudyNCT00003356



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:03 AM
Study NCT ID: NCT00003356
Status: COMPLETED
Last Update Posted: 2013-10-16
First Post: 1999-11-01

Brief Title: Rituximab Plus Interleukin-2 in Treating Patients With Lymphoma
Sponsor: University of Rochester
Organization: University of Rochester

Conditions & Keywords Data

Conditions:
Name
Lymphoma
Keywords:
Name View
splenic marginal zone lymphoma View
stage I grade 1 follicular lymphoma View
stage I grade 2 follicular lymphoma View
stage III grade 1 follicular lymphoma View
stage III grade 2 follicular lymphoma View
stage IV grade 1 follicular lymphoma View
stage IV grade 2 follicular lymphoma View
recurrent grade 1 follicular lymphoma View
recurrent grade 2 follicular lymphoma View
stage I mantle cell lymphoma View
contiguous stage II grade 1 follicular lymphoma View
contiguous stage II grade 2 follicular lymphoma View
contiguous stage II mantle cell lymphoma View
noncontiguous stage II grade 1 follicular lymphoma View
noncontiguous stage II grade 2 follicular lymphoma View
noncontiguous stage II mantle cell lymphoma View
stage III mantle cell lymphoma View
stage IV mantle cell lymphoma View
recurrent mantle cell lymphoma View
noncontiguous stage II small lymphocytic lymphoma View
noncontiguous stage II marginal zone lymphoma View
recurrent marginal zone lymphoma View
recurrent small lymphocytic lymphoma View
stage I marginal zone lymphoma View
stage I small lymphocytic lymphoma View
stage III small lymphocytic lymphoma View
stage III marginal zone lymphoma View
stage IV small lymphocytic lymphoma View
stage IV marginal zone lymphoma View
contiguous stage II marginal zone lymphoma View
contiguous stage II small lymphocytic lymphoma View
extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue View
nodal marginal zone B-cell lymphoma View